LM-24C5

DRUG2 trials

Sponsors

LaNova Medicines Limited

Conditions

Advanced Solid TumorAdvanced Solid Tumor Cancer

Phase 1

A Study of LM-24C5 For Advanced Solid Tumors

RecruitingNCT06187402

LaNova Medicines LimitedAdvanced Solid Tumor

Start: 2023-12-20End: 2026-12-30Target: 49Updated: 2025-09-09

Phase 2

Phase II Study of LM-24C5

RecruitingNCT07387081

LaNova Medicines LimitedAdvanced Solid Tumor Cancer

Start: 2025-12-15End: 2028-10-25Target: 130Updated: 2026-02-04